These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 21399881)

  • 1. Preclinical in vitro models from genetically engineered mice for breast and colon cancer (Review).
    Telang N; Katdare M
    Oncol Rep; 2011 May; 25(5):1195-201. PubMed ID: 21399881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial cell culture models for the prevention and therapy of clinical breast cancer (Review).
    Telang N; Katdare M
    Oncol Lett; 2012 Apr; 3(4):744-750. PubMed ID: 22740986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetically engineered mice as experimental tools to dissect the critical events in breast cancer.
    Menezes ME; Das SK; Emdad L; Windle JJ; Wang XY; Sarkar D; Fisher PB
    Adv Cancer Res; 2014; 121():331-382. PubMed ID: 24889535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening of Chemopreventive Agents in Animal Models: Results on Reproducibility, Agents of a Given Class, and Agents Tested During Tumor Progression.
    Lubet RA; Steele VE; Shoemaker RH; Grubbs CJ
    Cancer Prev Res (Phila); 2018 Oct; 11(10):595-606. PubMed ID: 30045934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of Genetically Engineered Mouse Models of Distinct Breast Cancer Subtypes.
    Usary J; Darr DB; Pfefferle AD; Perou CM
    Curr Protoc Pharmacol; 2016 Mar; 72():14.38.1-14.38.11. PubMed ID: 26995547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in Immunocompetent Mouse and Rat Models.
    Bu W; Li Y
    Cold Spring Harb Perspect Med; 2024 Mar; 14(3):. PubMed ID: 37217281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. If you give a mouse a mutation: comparing the therapeutic utility of renowned mouse models of human cancers.
    Shanker EM; Beck AP
    J Comp Pathol; 2023 May; 203():26-30. PubMed ID: 37236009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phenotypic screening approach to target p60AmotL2-expressing invasive cancer cells.
    Fonseca P; Cui W; Struyf N; Tong L; Chaurasiya A; Casagrande F; Zhao H; Fernando D; Chen X; Tobin NP; Seashore-Ludlow B; Lundqvist A; Hartman J; Göndör A; Östling P; Holmgren L
    J Exp Clin Cancer Res; 2024 Apr; 43(1):107. PubMed ID: 38594748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothesis: Induction of biomarkers for detection of colonic neoplasms.
    Bordonaro M; Lazarova D
    J Cancer; 2018; 9(1):166-173. PubMed ID: 29290782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical Modeling of Pathway-Targeted Therapy of Human Lung Cancer in the Mouse.
    Vaishnavi A; Kinsey CG; McMahon M
    Cold Spring Harb Perspect Med; 2024 Jan; 14(1):. PubMed ID: 37788883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducible mismatch repair streamlines forward genetic approaches to target identification of cytotoxic small molecules.
    Nguyen TP; Fang M; Kim J; Wang B; Lin E; Khivansara V; Barrows N; Rivera-Cancel G; Goralski M; Cervantes CL; Xie S; Peterson JM; Povedano JM; Antczak MI; Posner BA; Harvey CJB; Naughton BT; McFadden DG; Ready JM; De Brabander JK; Nijhawan D
    Cell Chem Biol; 2023 Nov; 30(11):1453-1467.e8. PubMed ID: 37607550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel preclinical model of the normal human breast.
    Wilby AJ; Cabral S; Zoghi N; Howell SJ; Farnie G; Harrison H
    J Mammary Gland Biol Neoplasia; 2024 May; 29(1):9. PubMed ID: 38695983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemically induced skin carcinogenesis: Updates in experimental models (Review).
    Neagu M; Caruntu C; Constantin C; Boda D; Zurac S; Spandidos DA; Tsatsakis AM
    Oncol Rep; 2016 May; 35(5):2516-28. PubMed ID: 26986013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination and Microbiota Manipulation Approaches for Colon Cancer Prevention in Rodent Models.
    Tosti E; Srivastava N; Edelmann W
    Cancer Prev Res (Phila); 2023 Aug; 16(8):429-438. PubMed ID: 37012205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammalian models of chemically induced primary malignancies exploitable for imaging-based preclinical theragnostic research.
    Liu Y; Yin T; Feng Y; Cona MM; Huang G; Liu J; Song S; Jiang Y; Xia Q; Swinnen JV; Bormans G; Himmelreich U; Oyen R; Ni Y
    Quant Imaging Med Surg; 2015 Oct; 5(5):708-29. PubMed ID: 26682141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbial considerations in genetically engineered mouse research.
    Franklin CL
    ILAR J; 2006; 47(2):141-55. PubMed ID: 16547371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse models for cancer research - current state and the perspective.
    Gercakova K; Poturnajova M; Tyciakova S; Rezuchova I; Matuskova M
    Neoplasma; 2024 Apr; 71(2):99-116. PubMed ID: 38766858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Insights in Murine Models for Breast Cancer: Present, Past and Future.
    Jain M; Goel A
    Curr Pharm Des; 2024 Jun; ():. PubMed ID: 38910416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inducible mismatch repair streamlines forward genetic approaches to target identification of cytotoxic small molecules.
    Nguyen TP; Fang M; Kim J; Wang B; Lin E; Khivansara V; Barrows N; Rivera-Cancel G; Goralski M; Cervantes CL; Xie S; Peterson JM; Povedano JM; Antczak MI; Posner BA; McFadden DG; Ready JM; De Brabander JK; Nijhawan D
    bioRxiv; 2023 Feb; ():. PubMed ID: 36865268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current views on
    Ferreira T; Azevedo T; Silva J; Faustino-Rocha AI; Oliveira PA
    Expert Opin Drug Discov; 2024 Feb; 19(2):189-207. PubMed ID: 38095187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.